These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24447945)

  • 21. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor.
    Thomson PA; Wray NR; Thomson AM; Dunbar DR; Grassie MA; Condie A; Walker MT; Smith DJ; Pulford DJ; Muir W; Blackwood DH; Porteous DJ
    Mol Psychiatry; 2005 May; 10(5):470-8. PubMed ID: 15452587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India.
    Verma R; Mukerji M; Grover D; B-Rao C; Das SK; Kubendran S; Jain S; Brahmachari SK
    Biol Psychiatry; 2005 Jul; 58(1):16-22. PubMed ID: 15992519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder.
    Prata D; Breen G; Osborne S; Munro J; St Clair D; Collier D
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):914-7. PubMed ID: 18165970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HTR2A-1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis.
    Gu L; Long J; Yan Y; Chen Q; Pan R; Xie X; Mao X; Hu X; Wei B; Su L
    J Neurosci Res; 2013 May; 91(5):623-33. PubMed ID: 23404241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing the antagonistic pleiotropy model of schizophrenia susceptibility by analysis of DAOA, PPP1R1B, and APOL1 genes.
    Carrera N; Arrojo M; Paz E; Ramos-Ríos R; Agra S; Páramo M; Brenlla J; Costas J
    Psychiatry Res; 2010 Sep; 179(2):126-9. PubMed ID: 20483474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for transmission disequilibrium at the DAOA gene locus in a schizophrenia family sample.
    Ma J; Sun J; Zhang H; Zhang R; Kang WH; Gao CG; Liu HS; Ma XH; Min ZX; Zhao WX; Ning QL; Wang SH; Zhang YC; Guo TW; Lu SM
    Neurosci Lett; 2009 Sep; 462(2):105-8. PubMed ID: 19560517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association between genetic variants at the ASCT1 gene and schizophrenia or bipolar disorder in a German sample.
    Skowronek MH; Georgi A; Jamra RA; Schumacher J; Becker T; Schmael C; Paul T; Deschner M; Höfels S; Wulff M; Schwarz M; Klopp N; Illig T; Propping P; Cichon S; Nöthen MM; Schulze TG; Rietschel M
    Psychiatr Genet; 2006 Dec; 16(6):233-4. PubMed ID: 17106422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANK3 gene polymorphisms and bipolar disorder: a meta-analysis.
    Roby Y
    Psychiatr Genet; 2017 Dec; 27(6):225-235. PubMed ID: 29068871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of affective (mood) disorders.
    Craddock N; Forty L
    Eur J Hum Genet; 2006 Jun; 14(6):660-8. PubMed ID: 16721402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder.
    Schumacher J; Jamra RA; Freudenberg J; Becker T; Ohlraun S; Otte AC; Tullius M; Kovalenko S; Bogaert AV; Maier W; Rietschel M; Propping P; Nöthen MM; Cichon S
    Mol Psychiatry; 2004 Feb; 9(2):203-7. PubMed ID: 14966479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study.
    Jönsson EG; Saetre P; Vares M; Andreou D; Larsson K; Timm S; Rasmussen HB; Djurovic S; Melle I; Andreassen OA; Agartz I; Werge T; Hall H; Terenius L
    Neuropsychobiology; 2009; 59(3):142-50. PubMed ID: 19439994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.
    Jagannath V; Gerstenberg M; Correll CU; Walitza S; Grünblatt E
    J Neural Transm (Vienna); 2018 Jan; 125(1):89-102. PubMed ID: 28864885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common and rare variants of DAOA in bipolar disorder.
    Maheshwari M; Shi J; Badner JA; Skol A; Willour VL; Muzny DM; Wheeler DA; Gerald FR; Detera-Wadleigh S; McMahon FJ; Potash JB; Gershon ES; Liu C; Gibbs RA
    Am J Med Genet B Neuropsychiatr Genet; 2009 Oct; 150B(7):960-6. PubMed ID: 19194963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits.
    So HC; Chau KL; Ao FK; Mo CH; Sham PC
    Psychol Med; 2019 Jun; 49(8):1286-1298. PubMed ID: 30045777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
    Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Schumacher J; Streit F; Meier S; Herms S; Hoffmann P; Lacour A; Witt SH; Reif A; Müller-Myhsok B; Lucae S; Maier W; Schwarz M; Vedder H; Kammerer-Ciernioch J; Pfennig A; Bauer M; Hautzinger M; Moebus S; Schenk LM; Fischer SB; Sivalingam S; Czerski PM; Hauser J; Lissowska J; Szeszenia-Dabrowska N; Brennan P; McKay JD; Wright A; Mitchell PB; Fullerton JM; Schofield PR; Montgomery GW; Medland SE; Gordon SD; Martin NG; Krasnov V; Chuchalin A; Babadjanova G; Pantelejeva G; Abramova LI; Tiganov AS; Polonikov A; Khusnutdinova E; Alda M; Cruceanu C; Rouleau GA; Turecki G; Laprise C; Rivas F; Mayoral F; Kogevinas M; Grigoroiu-Serbanescu M; Becker T; Schulze TG; Rietschel M; Cichon S; Fier H; Nöthen MM
    PLoS One; 2017; 12(2):e0171595. PubMed ID: 28166306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MDGA1 gene confers risk to schizophrenia and bipolar disorder.
    Li J; Liu J; Feng G; Li T; Zhao Q; Li Y; Hu Z; Zheng L; Zeng Z; He L; Wang T; Shi Y
    Schizophr Res; 2011 Feb; 125(2-3):194-200. PubMed ID: 21146959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association at SYNE1 in both bipolar disorder and recurrent major depression.
    Green EK; Grozeva D; Forty L; Gordon-Smith K; Russell E; Farmer A; Hamshere M; Jones IR; Jones L; McGuffin P; Moran JL; Purcell S; Sklar P; Owen MJ; O'Donovan MC; Craddock N
    Mol Psychiatry; 2013 May; 18(5):614-7. PubMed ID: 22565781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence variation in DOCK9 and heterogeneity in bipolar disorder.
    Detera-Wadleigh SD; Liu CY; Maheshwari M; Cardona I; Corona W; Akula N; Steele CJ; Badner JA; Kundu M; Kassem L; Potash JB; Gibbs R; Gershon ES; McMahon FJ;
    Psychiatr Genet; 2007 Oct; 17(5):274-86. PubMed ID: 17728666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees.
    Ohtsuki T; Ishiguro H; Detera-Wadleigh SD; Toyota T; Shimizu H; Yamada K; Yoshitsugu K; Hattori E; Yoshikawa T; Arinami T
    Mol Psychiatry; 2002; 7(9):954-61. PubMed ID: 12399948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SRD5A2 is associated with increased cortisol metabolism in schizophrenia spectrum disorders.
    Steen NE; Tesli M; Kähler AK; Methlie P; Hope S; Barrett EA; Larsson S; Mork E; Løvås K; Røssberg JI; Agartz I; Melle I; Djurovic S; Lorentzen S; Berg JP; Andreassen OA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1500-6. PubMed ID: 20800085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.